Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend of $0.75 per share. The dividend will be payable on October 21, 2024 to shareholders of record as of October 4, 2024. This announcement demonstrates Quest Diagnostics' commitment to returning value to its shareholders and reflects the company's financial stability and confidence in its future prospects.
Positive
- Consistent dividend payment indicates financial stability
- Shareholder value creation through regular cash distributions
- Maintained dividend level suggests company confidence
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DGX declined 0.11%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from the world's largest database of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302222903.html
SOURCE Quest Diagnostics